ConductScience.org, home

Trial · NCT01238211

Adverse events394

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

TypeEventOrgan systemGroupAffectedAt riskEvents
otherAnemiaBlood and lymphatic system disordersTreatment (Daunorubicin Hydrochloride, Cytarabine, Dasatinib)5861
otherBlood and lymphatic system disorders - OtherBlood and lymphatic system disordersTreatment (Daunorubicin Hydrochloride, Cytarabine, Dasatinib)561
otherDisseminated intravascular coagulationBlood and lymphatic system disordersTreatment (Daunorubicin Hydrochloride, Cytarabine, Dasatinib)861
otherFebrile neutropeniaBlood and lymphatic system disordersTreatment (Daunorubicin Hydrochloride, Cytarabine, Dasatinib)4761
otherLeukocytosisBlood and lymphatic system disordersTreatment (Daunorubicin Hydrochloride, Cytarabine, Dasatinib)661
otherLymph node painBlood and lymphatic system disordersTreatment (Daunorubicin Hydrochloride, Cytarabine, Dasatinib)361
otherAtrioventricular block first degreeCardiac disordersTreatment (Daunorubicin Hydrochloride, Cytarabine, Dasatinib)261
otherCardiac disorders - OtherCardiac disordersTreatment (Daunorubicin Hydrochloride, Cytarabine, Dasatinib)561
otherChest pain - cardiacCardiac disordersTreatment (Daunorubicin Hydrochloride, Cytarabine, Dasatinib)261
otherHeart failureCardiac disordersTreatment (Daunorubicin Hydrochloride, Cytarabine, Dasatinib)361
otherLeft ventricular systolic dysfunctionCardiac disordersTreatment (Daunorubicin Hydrochloride, Cytarabine, Dasatinib)361
otherMitral valve diseaseCardiac disordersTreatment (Daunorubicin Hydrochloride, Cytarabine, Dasatinib)161
otherPalpitationsCardiac disordersTreatment (Daunorubicin Hydrochloride, Cytarabine, Dasatinib)561
otherSinus bradycardiaCardiac disordersTreatment (Daunorubicin Hydrochloride, Cytarabine, Dasatinib)361
otherSinus tachycardiaCardiac disordersTreatment (Daunorubicin Hydrochloride, Cytarabine, Dasatinib)1661
otherVentricular arrhythmiaCardiac disordersTreatment (Daunorubicin Hydrochloride, Cytarabine, Dasatinib)261
otherEar and labyrinth disorders - OtherEar and labyrinth disordersTreatment (Daunorubicin Hydrochloride, Cytarabine, Dasatinib)161
otherHypothyroidismEndocrine disordersTreatment (Daunorubicin Hydrochloride, Cytarabine, Dasatinib)161
otherBlurred visionEye disordersTreatment (Daunorubicin Hydrochloride, Cytarabine, Dasatinib)661
otherConjunctivitisEye disordersTreatment (Daunorubicin Hydrochloride, Cytarabine, Dasatinib)361

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01238211/events